
    
      A randomized, controlled clinical trial in a split-mouth design was conducted on forty
      patients equally divided between two groups: a control group treated with full mouth scaling
      and root planing (SRP) and a test group treated with SRP combined with subgingivally
      delivered 0.01% NTZ sustained release Poloxamer 407/hyaluronic acid thermosensitive hydrogel.
    
  